ImmuPharma PLC (AIM:IMM, OTC:IMMPF) chief executive Tim McCarthy spoke to Thomas Warner at Proactive's London studio, following what he calls a "very busy time" for the specialty biopharmaceutical company.
He discusses the latest developments and next steps for the P140 platform, highlighting the importance of two upcoming meetings with the US FDA.